Levofloxacin Does Not Require Skin Testing
Skin testing with levofloxacin is not validated, not standardized, and should not be performed. 1
Why Skin Testing is Not Recommended for Levofloxacin
The 2022 Drug Allergy Practice Parameter from the Journal of Allergy and Clinical Immunology explicitly states that nonirritating concentrations for fluoroquinolone skin testing are difficult or impossible to determine due to these antibiotics' propensity to cause nonspecific mast cell degranulation 1. This means skin tests produce unreliable results with high false-positive rates.
Key Evidence Against Skin Testing:
- No validation exists: Unlike penicillin skin testing, there are no validated or standardized protocols for fluoroquinolone skin testing 1
- Technical limitations: Fluoroquinolones interact with the MRGPRX2 receptor, causing direct mast cell degranulation independent of IgE, making skin test interpretation impossible 1
- Poor predictive value: Research shows skin tests do not help identify the culprit drug or predict cross-reactivity 2
- No commercial tests available: There are no validated commercially available in vitro tests for IgE-mediated allergy to fluoroquinolones 1
What to Do Instead: Direct Drug Challenge
The guideline strongly recommends using a 1-step or 2-step drug challenge WITHOUT preceding skin testing to confirm tolerance in patients with a history of nonanaphylactic reactions to fluoroquinolones 1.
Clinical Approach:
For mild reactions (urticaria, rash) that occurred >5 years ago:
- Proceed with 1-step graded challenge with the implicated fluoroquinolone 1
For more severe or recent reactions:
- Consider single-dose or 2-step graded challenge with a different fluoroquinolone than the one implicated (approximately 50% cross-reactivity exists) 1
For patients with convincing anaphylaxis history who require fluoroquinolones:
- Drug tolerance induction may be considered if no acceptable alternatives exist 1
Important Context:
- 65-75% of patients with convincing histories of immediate-type reactions to fluoroquinolones tolerate the culprit antibiotic when rechallenged 1
- The majority of immediate reactions are NOT IgE-mediated 1
- Fluoroquinolone-related anaphylaxis rate is only 1-5 per 100,000 prescriptions 1
Common Pitfall to Avoid
Do not perform skin testing before administering levofloxacin, even in patients with a history of fluoroquinolone allergy. This practice has no scientific basis for fluoroquinolones 3 and will only lead to false-positive results that unnecessarily restrict antibiotic options. The only reliable method is direct oral challenge testing under appropriate monitoring 2.